Clinical Trial

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

Name: Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder — clinical trial record (NCT07226661)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study will evaluate the efficacy and safety of SPN-821 in adults with major depressive disorder

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-07.

Status change: Not Yet Recruiting → Recruiting 2026-03-19

Trial Details

NCT Number	NCT07226661
Lead Sponsor	Supernus Pharmaceuticals, Inc.
Conditions	Major Depressive Disorder (MDD)
Enrollment	230 participants
Start Date	2026-01-19
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-24